Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCM HD Trial: Single-dose ferric carboxymaltose in hemodialysis patients with iron deficiency anemia
jRCTs051230025Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Change in hemoglobin at 4 weeks. Started Oct 2023; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCTs051230025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051230025.